MicroRNAs Associated With HBV Infection And HBV-related HCC

被引:68
|
作者
Xie, Kun-Lin [1 ,2 ]
Zhang, Yan-Ge [3 ]
Liu, Jun [4 ]
Zeng, Yong [1 ,2 ]
Wu, Hong [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu 610041, Sichuan Provinc, Peoples R China
[2] Sichuan Univ, West China Hosp, Liver Transplantat Ctr, Chengdu 610041, Sichuan Provinc, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Burns & Plast Surg, Chengdu 610041, Sichuan Provinc, Peoples R China
[4] Sichuan Univ, West China Hosp, Dept Pharm, Chengdu 610041, Sichuan Provinc, Peoples R China
来源
THERANOSTICS | 2014年 / 4卷 / 12期
关键词
MicroRNA; Hepatitis B virus; Hepatocellular carcinoma; Diagnosis; Therapy; HEPATITIS-B-VIRUS; HUMAN HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR MICRORNA; ABERRANT DNA METHYLATION; HUMAN HEPATOMA-CELLS; LIVER-CANCER; X PROTEIN; DOWN-REGULATION; C-MET; MESENCHYMAL TRANSITION;
D O I
10.7150/thno.8715
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hepatitis B virus (HBV) infection is a global problem and a major risk factor for hepatocellular carcinoma (HCC). microRNAs (miRNAs) comprise a group of small noncoding RNAs regulating gene expression at the posttranslational level, thereby participating in fundamental biological processes, including cell proliferation, differentiation, and apoptosis. In this review, we summarize the roles of miRNAs in HBV infection, the recently identified mechanism underlying dysregulation of miRNAs in HBV-associated HCC, and their association with hepatocarcinogenesis. Moreover, we discuss the recent advances in the use of circulating miRNAs in the early diagnosis of HCC as well as therapies based on these aberrantly expressed miRNAs.
引用
收藏
页码:1176 / 1192
页数:17
相关论文
共 50 条
  • [41] Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
    Hui, Vicki Wing-Ki
    Chan, Stephen Lam
    Wong, Vincent Wai-Sun
    Liang, Lilian Yan
    Yip, Terry Cheuk-Fung
    Lai, Jimmy Che-To
    Yuen, Becky Wing-Yan
    Luk, Hester Wing-Sum
    Tse, Yee-Kit
    Lee, Hye-Won
    Chan, Henry Lik-Yuen
    Wong, Grace Lai-Hung
    [J]. JHEP REPORTS, 2020, 2 (06)
  • [42] Peroxisome Proliferator-Activated Receptors in HBV-Related Infection
    Dubuquoy, Laurent
    Louvet, Alexandre
    Hollebecque, Antoine
    Mathurin, Philippe
    Dharancy, Sebastien
    [J]. PPAR RESEARCH, 2009, 2009
  • [43] PRDM1 levels are associated with clinical diseases in chronic HBV infection and survival of patients with HBV-related hepatocellular carcinoma
    Li, Na
    Fan, Xiude
    Wang, Xiaoyun
    Deng, Huan
    Zhang, Kun
    Zhang, Xiaoge
    Wang, Ye
    Han, Qunying
    Lv, Yi
    Liu, Zhengwen
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 73 : 156 - 162
  • [44] A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib
    Yang, Yu
    Wen, Feng
    Li, Jianliang
    Zhang, Pengfei
    Yan, Wenhui
    Hao, Ping
    Xia, Feng
    Bi, Feng
    Li, Qiu
    [J]. LIVER INTERNATIONAL, 2015, 35 (09) : 2147 - 2154
  • [45] Elevated serum soluble CD14 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma
    Li, Na
    Zhu, Qiangian
    Yang, Cuiling
    Li, Fang
    Zhou, Zhihua
    Lv, Yi
    Sang, Jiao
    Han, Qunying
    Liu, Zhengwen
    [J]. TUMOR BIOLOGY, 2016, 37 (05) : 6607 - 6617
  • [46] A comparative study on proliferating activity between HBV-related and HCV-related small HCC
    YU ShaoJun
    [J]. World Journal of Gastroenterology, 1997, (04) : 38 - 39
  • [47] MUTATION SPECTRUM ASSOCIATED WITH THE PROGRESSION OF HBV-RELATED HEPATOCELLULAR CARCINOMA
    Woo, H. G.
    Kim, S. S.
    Cho, H. W.
    Kwon, S. M.
    Cho, H. J.
    Ahn, S. J.
    Cho, S. W.
    Cheong, J. Y.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S88 - S88
  • [48] Identification of potential miRNA–mRNA regulatory network contributing to pathogenesis of HBV-related HCC
    Weiyang Lou
    Jingxing Liu
    Bisha Ding
    Danni Chen
    Liang Xu
    Jun Ding
    Donghai Jiang
    Lin Zhou
    Shusen Zheng
    Weimin Fan
    [J]. Journal of Translational Medicine, 17
  • [49] Chronic HBV-related liver disease
    Rizzetto, Mario
    Ciancio, Alessia
    [J]. MOLECULAR ASPECTS OF MEDICINE, 2008, 29 (1-2) : 72 - 84
  • [50] Long term treatment with lamivudine and incidence of hepatocellular carcinoma (HCC) in HBV-related cirrhosis
    Di Marco, V
    Ferraro, D
    Bonura, C
    Parisi, P
    Sandonato, L
    Cappello, M
    Almasio, P
    Craxì, A
    Di Stefano, R
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 171 - 171